COURTNEY SHEEHAN: Open Payments
NPI 1427691278 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,964 in 138 payments from 24 companies in 2025. Trend: 2023 $2,399 · 2024 $2,293 · 2025 $2,964
Food & beverage: $2,763Consulting: $102Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $524 |
| ARS Pharmaceuticals Operations, Inc. | 20 | $455 |
| AstraZeneca Pharmaceuticals LP | 18 | $420 |
| CSL Behring | 11 | $229 |
| Amgen Inc. | 11 | $176 |
| BioCryst US Sales Co., LLC | 6 | $168 |
| GlaxoSmithKline, LLC. | 15 | $158 |
| Novartis Pharmaceuticals Corporation | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $104 |
| ADMA BioManufacturing LLC | 7 | $102 |
Products named: NEFFY, DUPIXENT, TEZSPIRE, AIRSUPRA, ORLADEYO, Andembry, TRELEGY ELLIPTA, Hizentra.
Industry payments across NC — which companies pay providers there.
